A patient surviving for eight years after proton and x-ray irradiation for advanced esophageal cancer

References

• Earlam R, Cuhana-Melo JR. Oesophageal squamous cell carcinoma. II. A critical review of radiotherapy. Br J Surg 1980; 67: 457–61
   PubMed Web of Science ®Google Scholar
• Okawa T, Kita M, Tanaka M, Ikeda M. Results of radiotherapy for inoperable locally advanced esophageal cancer. Int J Radiat Oncol Biol Phys 1989; 17: 49–54
   PubMedGoogle Scholar
• Herskovic A, Martz K, Al-Sarraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326: 1593–8
   PubMed Web of Science ®Google Scholar
• Smalley SR, Gunderson LL, Reddy EK, Williamson S. Radiotherapy alone in esophageal carcinoma: Current management and future directions of adjuvant, curative and palliative approaches. Semin Oncol 1994; 21: 467–73
   PubMedGoogle Scholar
• Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997; 15: 277–84
   PubMed Web of Science ®Google Scholar
• Chan A, Wong A. Is combined chemotherapy and radiation therapy equally effective as surgical resection in localized esophageal carcinoma?. Int J Radiat Oncol Biol Phys 1999; 45: 265–70
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer. Long-term follow-up of a prospective randomized trial (RTOG 85-01). JAMA 1999; 281: 1623–7
   PubMed Web of Science ®Google Scholar
• Lee M, Wynne C, Webb S, Nahum AE, Dearnaley D. A comparison of proton and megavoltage x-ray treatment planning for prostate cancer. Radiother Oncol 1994; 33: 239–53
   PubMed Web of Science ®Google Scholar
• Isacsson U, Montelius A, Jung B, Glimelius B. Comparative treatment planning between proton and X-ray therapy in locally advanced rectal cancer. Radiother Oncol 1996; 41: 263–72
   PubMed Web of Science ®Google Scholar
• Isacsson U, Hagberg H, Johansson KA, Montelius A, Jung B, Glimelius B. Potential advantages of protons over conventional radiation beams for paraspinal tumours. Radiother Oncol 1997; 45: 63–70
   PubMed Web of Science ®Google Scholar
• Bush DA, Slater JD, Bonnet R, et al. Proton-beam radiotherapy for early-stage lung cancer. Chest 1999; 116: 1313–9
   PubMed Web of Science ®Google Scholar
• Suit H. The Gray Lecture 2001: Coming technical advances in radiation oncology. Int J Radiat Oncol Biol Phys 2002; 53: 798–809
   PubMed Web of Science ®Google Scholar
• Kagei K, Tokuuye K, Okumura T, et al. Long-term results of proton beam therapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 2003; 55: 1265–71
   PubMed Web of Science ®Google Scholar
• Shioyama Y, Tokuuye K, Okumura T, et al. Clinical evaluation of proton radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2003; 56: 7–13
   PubMed Web of Science ®Google Scholar
• Tokuuye K, Akine Y, Kagei K, et al. Proton therapy for head and neck malignancies. Strahlenther Onkol 2004; 180: 96–101
   PubMedGoogle Scholar
• Igaki H, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for skull base chordoma. Int J Radiat Oncol Biol Phys 2004; 60: 1120–6
   PubMed Web of Science ®Google Scholar
• Sugahara S, Tokuuye K, Okumura T, et al. Clinical results of proton beam therapy for cancer of the esophagus. Int J Radiat Oncol Biol Phys 2005; 61: 76–84
   PubMed Web of Science ®Google Scholar
• Ask A, Johansson B, Glimelius B. The potential of proton beam radiation therapy in gastrointestinal cancer. Acta Oncol 2005; 44: 896–903
   PubMed Web of Science ®Google Scholar
• Glimelius B, Ask A, Bjelkengren G, Björk-Eriksson B, Blomquist E, Johansson B, et al. Number of patients potentially eligible for proton therapy. Acta Oncol 2005; 44: 836–49
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind CH. ”TNM classification of malignant tumours6th ed. John Wiley & Sons, Inc, New York 2002
   Google Scholar
• Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 1995; 31: 1341–6
   PubMed Web of Science ®Google Scholar
• Cooper JS, Guo MD, Herskovic A, et al. Chemoradiotherapy of locally advanced esophageal cancer: Long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group. JAMA 1999; 281: 1623–7
   PubMed Web of Science ®Google Scholar
• Al-Sarraf M, Martz K, Herskovic A, et al. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer: An intergroup study. J Clin Oncol 1997; 15: 277–84
   PubMed Web of Science ®Google Scholar